Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework

Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework - FZJ-2021-05945

Main document file(s):

Restricted fulltext file(s):

Similar records

guest :: login JuSER
		Search		Submit		Personalize Your alerts Your baskets Your searches		Help